Loading
Latest filing published 04 Oct 2011 for MEDCATH CORP, €66k.
No signal scores available.
James A. Parker discloses dealings in Medcath Corp to SEC (Form 4). In total, 14 filings cover trades dated from 9 March 2006 to 30 September 2011.
Sales make up the whole of the open-market record (3 sales, €142k). Other entries cover 8 share grants and 3 option exercises.
The latest filing, published on 4 October 2011, reports a share grant of €66k in Medcath Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations